|
A First-in-Human Pilot Study of 18F-MFBG Imaging for Evaluation of Neuroblastoma
|
1R01CA204093-01A1
|
$392,078
|
PANDIT-TASKAR, NEETA
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-41S1
|
$125,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-41S2
|
$62,491
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-41
|
$7,810,244
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
ABT-199 based therapies to treat neuroblastoma
|
1R01CA215610-01
|
$371,856
|
FABER, ANTHONY
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Altered mitochondria-ER signaling as a cause of chemotherapy resistance
|
5R21CA198430-02
|
$215,064
|
HOGARTY, MICHAEL
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Bench to bedside: non-invasive treatment of tumors in children
|
1U01CA202947-01A1
|
$350,585
|
KIM, PETER
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Bioinformatics: Systems Biology of Pediatric Cancers
|
ZIA BC 011002
|
$340,770
|
Khan, Javed
|
CCR (NCI)
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$474,811
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA008748-51S1
|
$125,746
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Cancer Center Support Grant
|
3P30CA008748-51S2
|
$40,000
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Cancer Center Support Grant
|
3P30CA008748-51S3
|
$100,000
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Cancer Center Support Grant
|
5P30CA008748-51
|
$12,352,942
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Cancer Center Support Grant
|
3P30CA082103-18S9
|
$6,765,398
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18SA
|
$124,999
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18SB
|
$59,999
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant Year 35 (CCSG)
|
3P30CA021765-38S1
|
$134,625
|
ROBERTS, CHARLES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant Year 35 (CCSG)
|
3P30CA021765-38S2
|
$174,253
|
ROBERTS, CHARLES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant Year 35 (CCSG)
|
5P30CA021765-38
|
$6,063,271
|
ROBERTS, CHARLES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Childhood Cancer Survivor Study
|
2U24CA055727-23
|
$3,616,741
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Clinical Development of Novel Drugs for Children with Refractory Cancers
|
ZIA SC 010354
|
$479,687
|
Widemann, Brigitte
|
CCR (NCI)
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-04S1
|
$1,393,520
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-04
|
$22,547,116
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-04
|
$400,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-48S1
|
$142,498
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-48
|
$2,645,581
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S2
|
$60,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S3
|
$100,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
2P30CA006516-52
|
$11,592,798
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S1
|
$112,500
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Deciphering the Molecular Pathways Driving p53 Dependent Cell Death
|
5F32CA199716-04
|
$60,990
|
GUARNIERI, ANNA
|
UNIVERSITY OF COLORADO DENVER
|
|
Developing Novel Therapies for Neuroblastoma and Rhabdomyosarcoma
|
ZIA BC 010806
|
$170,385
|
Khan, Javed
|
CCR (NCI)
|
|
Development of new antibody-based cancer therapies
|
ZIA BC 010891
|
$942,291
|
Ho, Mitchell
|
CCR (NCI)
|
|
Development of the first-in-class novel dual PI-3K/BRD4 inhibitor SF2523
|
2R42CA192656-02A1
|
$1,320,558
|
DURDEN, DONALD
|
SIGNALRX PHARMACEUTICALS, INC.
|
|
Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance
|
1P01CA217959-01
|
$2,296,936
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Discovering mechanisms of neuroblastoma tumorigenesis to improve patient outcomes
|
1R35CA220500-01
|
$683,163
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Discovery of New Differentiation Agents for Neuroblastoma Therapy
|
1R15CA213199-01A1
|
$461,575
|
DU, LIQIN
|
TEXAS STATE UNIVERSITY
|
|
Employing the Myc Transcriptional Network to Reveal Oncogenic Pathways
|
5R01CA057138-26
|
$635,460
|
EISENMAN, ROBERT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
ENHANCING T CELL THERAPY OF CANCER
|
5P01CA094237-15
|
$1,932,287
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Exosomes in tumor cell-mesenchymal stromal cell interaction
|
1R01CA207983-01A1
|
$423,016
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Fred & Pamela Buffett Cancer Center Support Grant
|
5P30CA036727-31
|
$2,107,000
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Georgetown University Lombardi Cancer Center Support Grant
|
3P30CA051008-24S1
|
$166,654
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
Georgetown University Lombardi Cancer Center Support Grant
|
5P30CA051008-24
|
$2,258,441
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
HAUSP inhibitors in p53-wild type and p53-mutant tumors
|
5R01CA193890-03
|
$366,000
|
GU, WEI
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
HiTIF Microscopy Core Facility
|
ZIC BC 011567
|
$858,349
|
Pegoraro, Gianluca
|
CCR (NCI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|